Aflac Incorporated (NYSE:AFL) Director Sells $106,790.00 in Stock

Aflac Incorporated (NYSE:AFL - Get Free Report) Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $106.79, for a total value of $106,790.00. Following the sale, the director now directly owns 26,096 shares of the company's stock, valued at $2,786,791.84. The trade was a 3.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Aflac Price Performance

Shares of AFL traded down $0.81 during mid-day trading on Monday, reaching $105.16. The company had a trading volume of 478,893 shares, compared to its average volume of 2,100,545. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The company has a market capitalization of $57.40 billion, a price-to-earnings ratio of 10.95, a P/E/G ratio of 3.24 and a beta of 0.84. Aflac Incorporated has a 1-year low of $85.50 and a 1-year high of $115.50. The company's 50 day simple moving average is $107.21 and its 200 day simple moving average is $106.59.

Aflac (NYSE:AFL - Get Free Report) last issued its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The firm had revenue of $3.40 billion during the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a net margin of 28.76% and a return on equity of 16.20%. The business's quarterly revenue was down 37.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.66 earnings per share. Analysts expect that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 2nd. Shareholders of record on Wednesday, May 21st will be issued a dividend of $0.58 per share. The ex-dividend date of this dividend is Wednesday, May 21st. This represents a $2.32 dividend on an annualized basis and a yield of 2.21%. Aflac's payout ratio is 36.25%.

Institutional Trading of Aflac

Several institutional investors and hedge funds have recently bought and sold shares of the company. Barclays PLC increased its position in shares of Aflac by 10.1% in the third quarter. Barclays PLC now owns 1,391,127 shares of the financial services provider's stock valued at $155,529,000 after acquiring an additional 127,911 shares during the period. Principal Financial Group Inc. grew its holdings in Aflac by 0.5% during the third quarter. Principal Financial Group Inc. now owns 643,686 shares of the financial services provider's stock valued at $71,964,000 after purchasing an additional 3,244 shares during the period. Wealth Enhancement Advisory Services LLC raised its holdings in Aflac by 0.7% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 146,363 shares of the financial services provider's stock valued at $16,363,000 after acquiring an additional 954 shares during the period. Graypoint LLC increased its holdings in shares of Aflac by 3.0% in the fourth quarter. Graypoint LLC now owns 6,506 shares of the financial services provider's stock worth $673,000 after purchasing an additional 190 shares during the last quarter. Finally, Czech National Bank lifted its position in Aflac by 5.6% during the fourth quarter. Czech National Bank now owns 108,405 shares of the financial services provider's stock valued at $11,213,000 after purchasing an additional 5,731 shares during the last quarter. 67.44% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

AFL has been the subject of several analyst reports. Barclays boosted their target price on shares of Aflac from $95.00 to $96.00 and gave the company an "underweight" rating in a research note on Thursday, May 1st. BMO Capital Markets began coverage on shares of Aflac in a research report on Thursday, January 23rd. They set a "market perform" rating and a $111.00 price target for the company. UBS Group boosted their price objective on shares of Aflac from $109.00 to $114.00 and gave the company a "neutral" rating in a research report on Wednesday, April 2nd. JPMorgan Chase & Co. lifted their price objective on shares of Aflac from $94.00 to $96.00 and gave the company a "neutral" rating in a research note on Wednesday, April 2nd. Finally, Piper Sandler increased their price objective on Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a research report on Wednesday, April 2nd. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $104.21.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.